FDA Alerts

FDA Alerts
FDA Alerts
09/22/2015
<p>What the Food and Drug Administration calls a 'breakthrough' drug is often not the same as what a layperson would call a breakthrough, a new study shows.</p>
09/22/2015
COPD
COPD
09/18/2015
The FDA has approved a drug already indicated for COPD treatment for the long-term, once-daily maintenance of asthma in individuals 12 years old and older.
09/18/2015
Schizophrenia
Schizophrenia
09/17/2015
The FDA has changed the requirements for prescribing, dispensing, and receiving a certain schizophrenia medication due to growing concerns of the risk of neutropenia.
09/17/2015
Dermatology
Dermatology
09/11/2015
The FDA has approved new options for hidradenitis suppurativa and hereditary orotic acuduria.
09/11/2015
Diabetes Q&A
Diabetes Q&A
08/31/2015
The FDA has warned of severe, disabling joint pain associated with the use of certain common diabetes drugs.
08/31/2015
Diabetes Q&A
Diabetes Q&A
08/28/2015
The FDA has approved new options for the treatment of type 2 diabetes and hypercholesterolemia, as well as a new continuous glucose monitoring system.
08/28/2015
FDA Alerts
FDA Alerts
08/24/2015
The FDA has granted Rare Pediatric Disease Designation for the medication, a therapy for patients with Duchenne muscular dystrophy who are open to skipping exon 51.
08/24/2015
FDA Alerts
FDA Alerts
08/19/2015
Sexual Dysfunction
Sexual Dysfunction
08/19/2015
The FDA has approved the first drug for the treatment of generalized hypoactive sexual desire disorder in premenopausal women.
08/19/2015
FDA Alerts
FDA Alerts
08/18/2015